|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.140 EUR | 0.00% |
|
-5.00% | -22.45% |
| 07-06 | Laboratorio Erfo continues buyback, acquires 15,000 treasury shares | AN |
| 06-29 | Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares | AN |
Company Valuation: Laboratorio Farmaceutico Erfo S.p.A.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 18.27 | 11.79 | 10.8 | 12.53 |
| Change | - | -35.47% | -8.4% | 16.03% |
| Enterprise Value (EV) 1 | 17.38 | 11.41 | 10.81 | 12.83 |
| Change | - | -34.34% | -5.31% | 18.7% |
| P/E | 25.5x | 19.1x | 30.8x | 17x |
| PBR | 2.33x | 1.43x | 1.44x | 1.57x |
| PEG | -0.3x | -1.4x | -0.8x | 0x |
| Capitalization / Revenue | 3.87x | 1.99x | 1.79x | 1.29x |
| EV / Revenue | 3.68x | 1.92x | 1.79x | 1.32x |
| EV / EBITDA | 11.8x | 8.02x | 10.1x | 7x |
| EV / EBIT | 17.6x | 13.6x | 20.6x | 12x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | 0.06 | - | - |
| Rate of return | - | 4.58% | - | - |
| EPS 2 | 0.0796 | 0.0686 | 0.0411 | 0.0865 |
| Distribution rate | - | 87.4% | - | - |
| Net sales 1 | 4.719 | 5.932 | 6.032 | 9.732 |
| EBITDA 1 | 1.474 | 1.423 | 1.065 | 1.832 |
| EBIT 1 | 0.987 | 0.8367 | 0.5239 | 1.066 |
| Net income 1 | 0.7161 | 0.5903 | 0.3528 | 0.737 |
| Net Debt 1 | -0.8895 | -0.3784 | 0.005767 | 0.2954 |
| Reference price 2 | 2.030 | 1.310 | 1.265 | 1.470 |
| Nbr of stocks (in thousands) | 9,000 | 9,000 | 8,537 | 8,524 |
| Announcement Date | 12/04/23 | 08/05/24 | 14/04/25 | 12/04/26 |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 11.09M | |
| 34.57x | 12.36x | 25.86x | 0.58% | 1,037B | |
| 27.4x | 6.26x | 17.33x | 2.1% | 615B | |
| 33x | 7.49x | 15.4x | 2.71% | 448B | |
| 17.76x | 4.4x | 10.85x | 3.01% | 326B | |
| 21.11x | 5.63x | 13.79x | 2.84% | 293B | |
| 21.21x | 4.47x | 12.37x | 1.97% | 264B | |
| 14.09x | 5.24x | 10.8x | 3.55% | 216B | |
| 24.01x | 6.34x | 11.18x | 2.76% | 198B | |
| -46.95x | 5.62x | 31.09x | 2.53% | 162B | |
| Average | 16.24x | 6.43x | 16.52x | 2.45% | 355.74B | |
| Weighted average by Cap. | 23.96x | 7.75x | 18.21x | 2.01% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ERFO Stock
- Valuation Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions
